AUS
NZ
UK
CA
USA
IND
Healthcare
Teva Pharmaceutical (NYSE:TEVA) Sees Shift Toward Branded Therapies Growth
March 17, 2026 01:41 PM PDT| By Anmol KhazanchiTeva Pharmaceutical Industries operates within the global healthcare and pharmaceutical sector, focusing on both generic medicines and specialized branded therapies. The company has undergone a notable transformation.
Biogen (NASDAQ:BIIB) Shows Momentum Across the Nasdaq Composite
March 17, 2026 12:00 AM PDT| By Anmol KhazanchiBiogen (NASDAQ:BIIB) draws focus as portfolio activity and neuroscience developments highlight its role in biotechnology, with ongoing discussions linked to movements in the nasdaq composite.
Biotechnology Activity Draws Attention Across Russell 1000
March 16, 2026 11:06 PM PDT| By Vivek SinghBiotechnology research focused on neuroscience continues to attract attention across healthcare discussions as clinical development, institutional participation, and scientific collaboration shape the evolving sector landscape.
Is S & P 500 Watching Bio-Rad?
March 16, 2026 04:30 AM PDT| By Vivek SinghBio-Rad Laboratories operates within the laboratory science sector, supplying research instruments and diagnostic technologies used across hospitals, universities, and biotechnology laboratories.
Scientific Instrument Firms Within Major US Market Benchmarks
March 16, 2026 04:30 AM PDT| By Vivek SinghScientific instrument manufacturers remain integrated within major US market benchmarks while supporting laboratory research, industrial testing, and analytical measurement across diverse scientific fields.
Alvotech (NASDAQ:ALVO) Emerges In Nasdaq Composite Biotech Discussions
March 16, 2026 12:00 AM PDT| By Anmol KhazanchiAlvotech (NASDAQ:ALVO) gains market attention as biosimilar medicine development and biotechnology activity highlight its presence within healthcare innovation discussions linked to the nasdaq composite.
Soleno (NASDAQ:SLNO) Gains Market Attention In Nasdaq Composite
March 16, 2026 12:00 AM PDT| By Anmol KhazanchiSoleno Therapeutics (NASDAQ:SLNO) draws attention as precision medicine research for rare metabolic disorders highlights its presence within biotechnology discussions connected to the nasdaq composite.
Mettler-Toledo (NYSE:MTD) Gains Market Visibility Across S&P 500 Index
March 16, 2026 12:00 AM PDT| By Anmol KhazanchiMettler-Toledo (NYSE:MTD) supports laboratories and industrial facilities with precision measurement technologies, reflecting the role of advanced manufacturing companies represented in the S&P 500 Index.
Teva Pharmaceutical (NYSE:TEVA) Performance Update Reveals Strong Sector Trends
March 14, 2026 11:44 AM PDT| By Anmol KhazanchiTeva Pharmaceutical Industries Ltd. operates in the global pharmaceutical industry with a focus on generic medicines. The company develops, produces, and markets generic pharmaceuticals alongside.
Johnson (NYSE:JNJ) Builds A Strong Presence In The Russell 1000 Index
March 14, 2026 12:00 AM PDT| By Anmol KhazanchiJohnson & Johnson (NYSE:JNJ) excels in healthcare, offering pharmaceuticals, medical devices, and consumer health products. As part of the Russell 1000 Index, it plays a key role in shaping the healthcare sector.
How Merck (NYSE:MRK) Solidifies Its Financial Strength In The S&P 500 Index?
March 14, 2026 12:00 AM PDT| By Anmol KhazanchiMerck (NYSE:MRK) is a leading biopharmaceutical company specializing in oncology, vaccines, and infectious diseases. As part of the S&P 500 Index, its financial strength and innovation play a key role in global healthcare.
Keros Therapeutics (NASDAQ:KROS) Gains Market Attention In Nasdaq Index
March 13, 2026 12:00 AM PDT| By Anmol KhazanchiKeros Therapeutics (NASDAQ:KROS) draws attention amid clinical research progress and institutional portfolio activity, highlighting its biotechnology development programs within healthcare discussions linked to the nasdaq index.
Bioventus (NASDAQ:BVS) Finds Fresh Attention In Nasdaq Today Sector
March 13, 2026 12:00 AM PDT| By Anmol KhazanchiBioventus (NASDAQ:BVS) draws attention as institutional portfolio shifts and orthobiologic therapy developments are discussed within broader healthcare technology trends influencing Nasdaq Today.
Alliance Laundry (NYSE:ALH) Quarterly Update Discusses Challenges And Solutions
March 12, 2026 04:20 PM PDT| By Anmol KhazanchiAlliance Laundry, a leading manufacturer in commercial and residential laundry equipment, has released its quarterly results, demonstrating growth across multiple segments.
Novo Nordisk (NYSE:NVO) After Focuses On Cutting Edge Research And Development
March 12, 2026 02:44 PM PDT| By Anmol KhazanchiNovo Nordisk operates in the global pharmaceuticals and biotech sector, with a strong focus on innovative treatments and therapies. The company has maintained consistent engagement across multiple therapeutic areas.
Gilead (NASDAQ:GILD) Institutional Focus Rises In Nasdaq 100 Index
March 12, 2026 12:00 AM PDT| By Anmol KhazanchiGilead Sciences (NASDAQ:GILD) gains renewed attention following brokerage coverage initiation, highlighting its role in antiviral, oncology, and cell therapy research within healthcare discussions tied to the nasdaq 100 index.
Vertex Pharma (NASDAQ:VRTX) Market Focus Builds Across Nasdaq Index
March 12, 2026 12:00 AM PDT| By Anmol KhazanchiVertex Pharmaceuticals (NASDAQ:VRTX) draws market attention as rare disease research, biotechnology innovation, and institutional activity highlight its role within healthcare discussions linked to the nasdaq index.
AMN Healthcare Services (NYSE:AMN) Driving Excellence In Modern Medical Facilities
March 11, 2026 03:39 PM PDT| By Anmol KhazanchiAMN Healthcare Services operates in the healthcare staffing sector in the United States. The company provides a comprehensive range of workforce solutions catering to hospitals, clinics, and other medical facilities.
Merit Medical Systems (NASDAQ:MMSI) Gains Spotlight Across Nasdaq Index
March 11, 2026 12:00 AM PDT| By Anmol KhazanchiMerit Medical Systems (NASDAQ:MMSI) draws market attention as institutional participation and coverage updates emerge, with healthcare technology companies often discussed alongside broader movements in the nasdaq index.
Sarepta (NASDAQ:SRPT) Healthcare Tech Buzz In Nasdaq Composite
March 11, 2026 12:00 AM PDT| By Anmol KhazanchiSarepta Therapeutics (NASDAQ:SRPT) draws market focus through genetic medicine research targeting rare neuromuscular disorders, with biotechnology companies often discussed alongside movements in the nasdaq composite.
